{"AMD": {"Ticker": "AMD", "Company": "Advanced Micro Devices", "Sector": "Information Technology", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "Craig Hallum", "Rating_Change": "Hold to Buy", "Target_Change": "$76 to $100"}, {"Date": "2023-05-03", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$98 to $95"}, {"Date": "2023-04-24", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$112 to $115"}, {"Date": "2023-03-02", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Strong Buy", "Target_Change": "$100"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Raymond James", "Craig Hallum", "Susquehanna"], "Price_Target": 102.5}, "AMCR": {"Ticker": "AMCR", "Company": "Amcor", "Sector": "Materials", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$11.60 to $10.80"}, {"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Underperform to Hold", "Target_Change": ""}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies", "JP Morgan"], "Price_Target": 0}, "CMA": {"Ticker": "CMA", "Company": "Comerica", "Sector": "Financials", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2023-04-06", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": "$84 to $57"}, {"Date": "2023-04-06", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$75 to $44"}, {"Date": "2023-03-15", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$68"}, {"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Odeon", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$77 to $82"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wolfe Research", "Piper Sandler", "JP Morgan", "Odeon", "UBS", "Raymond James"], "Price_Target": 62.75}, "MAR": {"Ticker": "MAR", "Company": "Marriott International", "Sector": "Consumer Discretionary", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$204"}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$180"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Bernstein", "Evercore ISI"], "Price_Target": 192.0}, "TAP": {"Ticker": "TAP", "Company": "Molson Coors Beverage Company", "Sector": "Consumer Staples", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$59 to $64"}, {"Date": "2023-04-21", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Underweight", "Target_Change": "$51 to $59"}, {"Date": "2023-02-17", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$55"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "JP Morgan"], "Price_Target": 59.33}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2023-05-03", "Rating": [{"Date": "2023-05-03", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": ""}, {"Date": "2023-04-11", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$135 to $148"}, {"Date": "2023-03-31", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Underperform to Hold", "Target_Change": "$115 to $130"}, {"Date": "2023-03-29", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Sell", "Target_Change": "$112"}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$135 to $145"}], "Score": 0.8, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Piper Sandler", "Jefferies", "UBS", "BofA Securities", "Evercore ISI"], "Price_Target": 133.75}}